| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Dec 3, 2024 | CASSAVA SCIENCES INC | CFO | Sell | 22.5 | -61,800 | -84.31% | ✗ | $238.5K |
| Aug 12, 2022 | Aug 16, 2022 | CASSAVA SCIENCES INC | CFO | Buy | 91.3 | +2,500 | 12.95% | ✗ | $49.9K |
| Sep 17, 2020 | Sep 17, 2020 | CASSAVA SCIENCES INC | CFO | Buy | 95.0 | +12,000 | 29.56% | ✗ | $84.4K |
| Dec 19, 2019 | Dec 19, 2019 | CASSAVA SCIENCES INC | CFO | Buy | 90.0 | +5,300 | 53.00% | ✗ | $10K |
| May 14, 2019 | May 15, 2019 | CASSAVA SCIENCES INC | CFO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $10.6K |
| Feb 13, 2017 | Feb 15, 2017 | Aspira Women's Health Inc. | Sr VP Finance & CAO | Buy | 90.0 | +3,347 | 12.62% | ✗ | $4.7K |
| Nov 18, 2014 | Nov 20, 2014 | Aspira Women's Health Inc. | VP Finance & CAO | Buy | 90.0 | +5,000 | 23.23% | ✗ | $7.1K |
| Nov 15, 2011 | Nov 15, 2011 | Aspira Women's Health Inc. | Chief Accounting Officer | Buy | 91.3 | +19,525 | 976.25% | ✗ | $23K |